SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Aono S, Keino H, Ono T, Yasuda Y, Tokita Y, Matsui F, Taniguchi M, Sonta S, Oohira A. 2000. Genomic organization and expression pattern of mouse neuroglycan C in the cerebellar development. J Biol Chem 275: 337342.
  • Bandtlow CE, Zimmermann DR. 2000. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 80: 12671290.
  • Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. 1999. Function of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729777.
  • Bode-Lesniewska B, Dours-Zimmermann MT, Odermattm BF, Briner J, Heitz PU, Zimmermann DR. 1996. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 44: 303312.
  • Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. 1992. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360: 361364.
  • Chang D, Woo JS, Campanelli J, Scheller RH, Ignatius MJ. 1997. Agrin inhibits neurite outgrowth but promotes attachment of embryonic motor and sensory neurons. Dev Biol 181: 2135.
  • Coppock DL, Kopman C, Scandalis S, Gilleran S. 1993. Preferential gene expression in quiescent human lung fibroblasts. Cell Growth Differ 4: 483493.
  • Coppock D, Kopman C, Gudas J, Cina-Poppe DA. 2000. Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29. Biochem Biophys Res Commun 269: 604610.
  • Cotman SL, Halfter W, Cole GJ. 1999. Identification of the extracellular ligands for the heparan sulfate proteoglycan agrin. Exp Cell Res 249: 5464.
  • Couchman JR, Chen L, Woods A. 2001. Syndecans and cell adhesion. Int Rev Cytol 207: 113150.
  • Cs-Szabó G, Melching LI, Roughley PJ, Glant TT. 1997. Changes in messenger RNA and protein levels of proteoglycans and link protein in human ostheoarthritic cartilage samples. Arthritis Rheum 40: 10371045.
  • Csordás G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, Nugent MA, Hajnóczky G, Iozzo RV. 2000. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 275: 3287932887.
  • De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. 1996. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 271: 1896118965.
  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817825.
  • Engel S, Isenmann S, Stander M, Rieger J, Bahr M, Weller M. 1999. Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration. J Neuroimmunol 99: 1318.
  • Evanko SP, Angello JC, Wight TN. 1999. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 10041013.
  • Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH, Faissner A, Fawcett JW. 1999. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 19: 87788788.
  • Fischer JW, Kinsella MG, Clowes MM, Lara S, Clowes AW, Wight TN. 2000. Local expression of bovine decorin by cell-mediated gene transfer reduces neointimal formation after balloon injury in rats. Circ Res 86: 676683.
  • Fischer JW, Kinsella MG, Levkau B, Cloves AW, Wight TN. 2001. Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thromb Vasc Biol 21: 777784.
  • Goretzki L, Burg MA, Grako KA, Stallcup WB. 1999. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem 274: 1683116837.
  • Halfter W, Schurer B, Yip L, Tsen G, Lee JA, Cle GJ. 1997. Distribution and substrate properties of agrin, a heparan sulfate proteoglycan of developing axonal pathways. J Comp Neurol 383: 117.
  • Hausser H, Gröning A, Hasilik A, Schönherr E, Kresse H. 1994. Selective inactivity of TGF-β/decorin complexes. FEBS Letters 353: 243245.
  • Hildebrand A, Romaris M, Rasmussen LM, Heinegård D, Twardzik DR, Border WA, Ruoslahti E. 1994. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-β. Biochem J 302: 527534.
  • Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. 2001. Versican interacts with chemokines and modulated cellular responses. J Biol Chem 276: 52285234.
  • Häkkinen L, Strassburger S, Kähäri V-M, Scott PG, Eichstetter I, Iozzo RV, Larjava H. 2000. A role for decorin in the structural organization of periodontal ligament. Lab Invest 80: 18691880.
  • Iozzo RV. 1998. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67: 609652.
  • Iozzo RV, Chakrani F, Perrotti D, McQuillan DJ, Skorski T, Calabretta B, Eichstetter I. 1999. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci USA 96: 30923097.
  • Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA. 1996. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 2: 418423.
  • Järveläinen HT, Iruela-Arispe ML, Kinsella MG, Sandell LJ, Sage EH, Wight TN. 1992. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 203: 395401.
  • Kappler J, Junghans U, Koops A, Stichel CC, Hausser HJ, Kresse H, Müller HW. 1997. Chondroitin/dermatan sulphate promotes the survival of neurons from ratt embryonic neocortex. Eur J Neurosci 9: 306318.
  • Kishimoto J, Ehama R, Wu L, Jiang S, Jiang N, Burgeson RE. 1999. Selective activation of versican promoter by epithelial-mesenchymal interactions during hair follicle development. Proc Natl Acad Sci USA 96: 73367341.
  • Kolb M, Margetts PJ, Sime PJ, Gauldie J. 2001. Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280: L1327L1334.
  • Koops A, Kappler J, Junghans U, Kuhn G, Kresse H, Müller HW. 1996. Cultured astrocytes express biglycan, a chondroitin/dermatan sulfate proteoglycan supporting the survival of neocortical neurons. Brain Res Mol Brain Res 41: 6573.
  • Laine P, Reunanen N, Ravanti L, Foschi M, Santra M, Iozzo RV, Kähäri VM. 2000. Activation of extracellular signal-regulated protein kinase 1,2 results in down-regulation of decorin expression in fibroblasts. Biochem J 349: 1925.
  • Lander AD, Selleck SB. 2000. The elusive functions of proteoglycans: in vivo veritas. J Cell Biol 148: 227232.
  • Li H, Leung TC, Hoffman S, Balsamo J, Lilien J. 2000. Corrdinate regulation of cadherin and integrin function by the chondroitin sulfate proteoglycan neurocan. J Cell Biol 149: 12751288.
  • Liang Y, Haring M, Roughley PJ, Margolis RK, Margolis RU. 1997. Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J Cell Biol 139: 851864.
  • Lin X, Perrimon N. 2000. Role of heparan sulfate proteoglycans in cell-cell signalling in Drosophila. Matrix Biol 19: 303307.
  • Margolis RU, Margolis RK. 1997. Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding. Cell Tissue Res 290: 343348.
  • Markmann A, Hausser H, Schönherr E, Kresse H. 2000. Influence of decorin expression on transforming growth factor-β-mediated collagen gel retraction and biglycan induction. Matrix Biol 19: 631636.
  • Mauviel A, Santra M, Chen YQ, Uitto J, Iozzo RV. 1995. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor J Biol Chem 270: 1169211700.
  • McKeon RJ, Jurynec MJ, Buck CR. 1999. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 19: 1077810788.
  • Milev P, Maurel P, Chiba A, Mevissen M, Popp S, Yamaguchi Y, Margolis RK, Margolis RU. 1998a. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem Biophys Res Commun 247: 207212.
  • Milev P, Monnerie H, Popp S, Margolis RK, Margolis RU. 1998b. The core protein of the chondroitin sulfate proteoglycan phosphacan is a high affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity. J Biol Chem 273: 2143921442.
  • Mongiat M, Taylor K, Otto J, Aho S, Uitto J, Whitelock JM, Iozzo RV. 2000. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem 275: 70957100.
  • Mongiat M, Otto J, Oldershaw R, Ferrer F, Sato JD, Iozzo RV. 2001. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. J Biol Chem 276: 1026310271.
  • Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. 1998. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 101: 406412.
  • Niederost BP, Zimmermann DR, Schwab ME, Bandtlow CE. 1999. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J Neurosci 19: 89798989.
  • Ohtsuki T, Suzu S, Hatake K, Nagata N, Miura Y, Motoyoshi K. 1993. A proteoglycan form of macrophage colony-stimulating factor that binds to bone-derived collagens and can be extracted from bone matrix. Biochem Biophys Res Commun 190: 215222.
  • Olin AI, Mörgelin M, Sasaki T, Timpl R, Heinegård D, Aspberg A. 2001. The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 276: 12531261.
  • Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ. 1998. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 4: 575580.
  • Ornitz DM. 2000. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22: 108112.
  • Partenheimer A, Schwarz K, Wrocklage C, Kölsch E, Kresse H. 1995. Proteoglycan form of colony-stimulating factor-1 (proteoglycan-100). Stimulation of activity by glycosaminoglycan removal and proteolytic processing. J Immunol 155: 55575565.
  • Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP. 1998. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 273: 31213124.
  • Penc SF, Pomahac B, Eriksson E, Detmar M, Gallo RL. 1999. Dermatan sulfate activates nuclear factor-κB and induces endothelial and circulating intercellular adhesion molecule-1. J Clin Invest 103: 13291335.
  • Rapraeger AC. 2000. Syndecan-regulated receptor signaling. J Cell Biol 149: 995998.
  • Riquelme C, Larrain J, Schönherr E, Henriquez JP, Kresse H, Brandan E. 2001. Antisense inhibition of decorin expression in myoblasts decreases cell respnsiveness to transforming growth factor β and accelerates skeletal muscle differentiation. J Biol Chem 276: 35893596.
  • Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. 1995. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 92: 70167020.
  • Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. 1997. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 100: 149157.
  • Santra M, Eichstetter I, Iozzo RV. 2000. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 275: 3515335161.
  • Schaefer L, Raslik I, Gröne HJ, Schönherr E, Macakova K, Ugorcakova J, Budny S, Schaefer RM, Kresse H. 2001. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 15: 559561.
  • Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. 2000. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113: 807816.
  • Schönherr E, Hausser H-J. 2000. Extracellular matrix and cytokines: a functional unit. Develop Immunol 7: 89101.
  • Schönherr E, Broszat M, Brandan E, Bruckner P, Kresse H. 1998. Decorin core protein fragment Leu155-Val260 interacts with TGF-β but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 335: 241248.
  • Schönherr E, O'Connell BC, Schittny J, Robenek H, Fastermann D, Fisher LW, Plenz G, Vischer P, Young MF, Kresse H. 1999. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 78: 4455.
  • Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K. 2000. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21WAF1/CIP1 but not p27Kip1. J Biol Chem 276.
  • Sporn MB. 1999. TGF-β: 20 years and counting. Microbes Infect 1: 12511253.
  • Sugahara K, Kitagawa H. 2000. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol 10: 518527.
  • Takeuchi Y, Kodama Y, Matsumoto T. 1994. Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem 269: 3263432638.
  • Wu Y, Zhang A, Cao L, Chen L, Lee V, Zheng P-S, Kiani C, Adams ME, Ang LC, Paiwand F, Yang BB. 2001. Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem 276: 1417814186.
  • Yamaguchi Y. 2000. Lecticans: organizers of the brain extracellular matrix. CMLS Cell Mol Life Sci 57: 276289.
  • Yamaguchi Y, Ruoslahti E. 1988. Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation. Nature 336: 244246.
  • Yamaguchi Y, Mann DM, Ruoslahti E. 1990. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346: 281284.
  • Yang BL, Zhang Y, Cao L, Yang BB. 1999. Cell adhesion and proliferation mediated through the G1 domain of versican. J Cell Biochem 72: 210220.
  • Zhang Y, Cao L, Yang BL, Yang BB. 1998a. The G3 domain of versican enhances cell proliferation via EGF-like motifs. J Biol Chem 273: 2134221351.
  • Zhang Y, Cao L, Kiani CG, Yang BL, Yang BB. 1998b. The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J Biol Chem 273: 3305433063.
  • Zhang Y, Cao L, Kiani C, Yang BL, Hu W, Yang BB. 1999. Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like domains. J Cell Biochem 73: 445457.
  • Zhang Y, Wu Y, Cao L, Lee V, Chen L, Lin Z, Kiani C, Adams ME, Yang BB. 2001. Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3. Exp Cell Res 263: 3342.
  • Zhao J, Sime PJ, Bringas P Jr, Gauldie J, Warburton D. 1999. Adenovirus-mediated decorin gene transfer prevents TGF-β-induced inhibition of lung morphogenesis. Am J Physiol 277: L412L422.
  • Zimmermann DR, Dours-Zimmermann MT, Schubert M, Bruckner-Tudeman L. 1994. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 124: 817825.